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Abstract: In order to study the effects of iron oxide (IO) nanoparticles on Staphylococcus 
aureus, IO nanoparticles were synthesized via a novel matrix-mediated method using polyvinyl 
alcohol (PVA). The IO nanoparticles were characterized by transmission electron microscopy 
and dynamic light scattering. Further, S. aureus were grown in the presence of three different 
IO nanoparticle concentrations for four, 12, and 24 hours. Live/dead assays were performed 
and the results provide evidence that IO/PVA nanoparticles inhibited S. aureus growth at the 
highest concentration (3 mg/mL) at all time points.
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Introduction
Iron oxide (IO) has been widely used in biomedical research because of its 
biocompatibility and magnetic properties.1,2 Nanoparticles of IO, with sizes less than 
100 nm, have been developed as contrast agents for magnetic resonance imaging 
(MRI),3,4 as hyperthermia agents,5,6 and as carriers for targeted drug delivery to treat 
several types of cancer.7,8 It is further believed that through the use of magnetic 
nanoparticles, an optimal drug delivery system can be developed by using an external 
magnetic field to direct such nanoparticles to desirable sites (such as implant infection) 
for immediate treatment9 (Figure 1).
Staphylococcus aureus is one of the most common human pathogens, and leads to 
many types of infection.10 This bacterium is responsible not only for local infections, such 
as wounds or postoperative infection, but also for prosthetic infection (such as through the 
use of catheters, endotracheal tubes, and other biomaterials).11–13 S. aureus is also known 
to possess an increasing ability to resist antibiotics14–16 (such as penicillin, methicillin, 
tetracycline, erythromycin, and vancomycin). Thus, it is necessary to find an alternative 
treatment (perhaps without the use of antibiotics) for S. aureus infection that is directed 
to the site of infection, localized, and difficult for bacteria to formulate resistance.
Along this line, some have hypothesized that reactive oxygen species (ROS) 
generated by Fe3O4 nanoparticles could kill bacteria without harming non-bacterial 
cells.17 Specifically, Pareta et al cultured osteoblasts (bone-forming cells) with IO 
nanoparticles (at a concentration of 4.25 mg/mL) and found that cell density was 
greatly enhanced in the presence of IO nanoparticles compared with cells cultured 
without nanoparticles.9
Polyvinyl alcohol (PVA) is a polymer commonly used in biomedical applications 
because of its biocompatibility.18 IO nanoparticles stabilized by PVA were developed International Journal of Nanomedicine 2010:5 278
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in several studies focused on targeted drug delivery.19–21 
In the present study, PVA was used as a matrix to deliver 
nonagglomerated nanoparticles, as suggested by previous 
researchers.22,23 The objectives of this study were to design, 
synthesize, and characterize PVA/IO nanoparticles and 
investigate the bactericidal activity of such nanoparticles 
when cultured with S. aureus.
Materials and methods
Iron oxide nanoparticle synthesis
IO nanoparticles were synthesized in situ via a matrix-
mediated method using PVA similar to previously suggested 
processes.24,25 Briefly, an aqueous solution of PVA (Acros 
Organics, Geel, Belgium) was mixed with equal volumes of 
ferrous/ferric aqueous solutions under ambient conditions. 
The iron-loaded PVA gels were soaked in stoichiometric 
amounts of warm aqueous solutions of NaOH. The resulting 
ferrosoferric hydroxide dehydrates gave brownish precipita-
tions in the polymer solution.
Characterization of iron oxide/PVA
A droplet of IO nanoparticles was placed on a transmission 
electron microscopy (TEM) copper grid and allowed to dry. The 
imaging was carried out at 100 kV on a Philips EM420 TEM 
(Philips, Amsterdam, The Netherlands) and size calculations were 
carried out with ImageJ (version 1.42q; NIH, Bethseda, MD).
To measure the hydrodynamic size of the nanoparticles, 
100 µL of the particle solution was diluted with 1.5 mL of 
water and placed into a cuvette of a Zetasizer-nano instrument 
(Malvern, Philadelphia, PA). Experiments were conducted in 
triplicate to obtain an average number-size distribution. The 
same apparatus was used to measure zeta potentials.
X-ray diffraction (XRD) on dried IO nanoparticle powders 
was performed on a Siemens D500 (Siemens, Berlin, Germany) 
within a 2θ range of 20–80 degrees using Cu Kα radiation.
The magnetic properties of the dried nanoparticles 
were obtained using vibrating sample magnometry (VSM, 
LakeShore 7040) at room temperature.
S. aureus culture
S. aureus were obtained in frozen form from the American 
Type Culture Collection (ATCC; ATCC 25923). The bacteria 
were thawed on ice for 20 minutes before being plated on an 
agar plate. The plate was dried before incubation for 16 hours 
in a standard cell culture environment (37°C, 5% CO2, and 
95% air). A single colony of S. aureus was selected using 
a 10 µL loop (Sigma, St. Louis, MO) and inoculated into 
centrifuge tubes containing 5 mL of tryptic soy broth. Bac-
teria in centrifuge tubes were then incubated at 37°C under 
agitation at 200 rpm for another 16 hours. At that point, the 
bacteria solution was diluted in tryptic soy broth to an optical 
density of 0.52 at 562 nm using a microplate reader (Spectra-
Max300; Molecular Devices, Sunnyvale, CA). According to 
the standard curve correlating bacteria number with optical 
density, this value was equivalent to 5 × 106 cells/mL. The cells 
were further diluted in tryptic soy broth to 5 × 104 cells/mL 
before being added to a new centrifuge tube at 3 mL/tubes.
Concentrated IO nanoparticles in solution were added 
to bacteria tubes at different doses [30 µg/mL (low dose), 
300 µg/mL (medium dose), and 3 mg/mL (high dose)]. A tube 
of bacteria without nanoparticles served as a control. The IO 
solution was also added to tubes containing only tryptic soy at 
the same concentration as above and this served as a particle 
control. Bacteria were then incubated under agitation for 
four hours, 12 hours, and 24 hours before a 200 µL bacteria 
solution was transferred to a 96-well plate for optical density 
readings at 562 nm using a microplate reader.
S. aureus live/dead assay
After four, 12, and 24 hours of incubation, 100 µL of the 
bacteria suspension was transferred into a 96-well plate. 
A live/dead assay was performed according to manufacturer’s 
instructions (Live/Dead BacLight, L7007; Invitrogen, Carls-
bad, CA). Briefly, two solutions containing SYTO 9 dye 
and propidium iodide were mixed and diluted with double 
distilled water before being added to a bacteria solution at 
100 µL/well. The plate was incubated at room temperature 
in the dark for 15 minutes. Fluorescence intensities for live 
cells (excitation: 485 nm, emission: 530 nm) and dead cells 
(excitation: 485 nm, emission: 630 nm) were measured using 
a fluorescence microplate reader (SpectraMax M5; Molecular 
Devices). The two intensities were divided and reported as 
the ratio of live/dead bacteria.
Magnetic field line
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Figure 1 A simplified design for a magnetic drug delivery system in which magnetic 
nanoparticles coated with drugs are directed to infection sites by an external 
  magnetic field.International Journal of Nanomedicine 2010:5 279
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Statistical analysis
All experiments were conducted in triplicate and repeated 
at least three times. Differences between means were 
determined using a Student’s t-test.
Results and discussion
Nanoparticle synthesis  
and characterization
TEM images of the synthesized PVA-coated IO nanoparticles 
(Figure 2) showed that the size of the nanoparticles was 
9 nm ± 4 nm. The nanoparticles formed necklace-like 
chains with a typical length of approximately 100–200 nm. 
A similar formation was reported in an earlier study, in 
which IO nanoparticles were believed to precipitate along 
the polymer chain of PVA.22 The nanoparticle solution was 
a clear brownish color and no major types of aggregation 
were visible after months from synthesis.
The hydrodynamic diameter measurement results 
(Figure 3) showed that with the PVA coating, the IO 
chain-like particles had an average size of 140 nm.
The measured average zeta potential was −19 mV 
(Figure 4). This low value suggested that the nanoparticle 
solution was stable mostly because of steric repulsion but 
not electrostatic repulsion. The long hydrophilic chains of 
the PVA associated with water molecules, thus, preventing 
agglomeration.
The XRD pattern confirmed that the final product was a 
mixture of Fe3O4 and γ-Fe2O3 (Figure 5). The existence of 
γ-Fe2O3 was common and was because of the oxidation of 
Fe3O4 during synthesis.26
According to the VSM results (Figure 6), the negligible 
coercivity of IO nanoparticles showed properties of 
superparamagnetic materials, meaning that these nanoparticles 
do not retain any magnetism after removal of a magnetic field. 
The high magnetization and superparamagnetic properties 
are highly desirable for biomedical applications because 
larger magnetic particles form aggregates after exposure to a 
magnetic field.2 The saturation magnetization of the synthesized 
IO nanoparticles was 15 emu/g. As expected, because of the 
PVA coating saturation, magnetization of nanoparticles was 
lower than that of bulk phase magnetite (∼90 emu/g).
Bactericidal activity of PVA-coated IO
After four hours of incubation, the optical density measurements 
(Figure 7) showed that there was no significant difference 
in bacteria numbers in the presence of IO nanoparticles.   
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Figure 2 Transmission electron microscope images of the synthesized IO/PVA 
nanoparticles. Scale bar = 20 nm.
Abbreviations: IO, iron oxide; PVA, polyvinyl alcohol.
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Figure 3 IO nanoparticle size distribution as measured by dynamic light scattering.
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However, and more importantly, the results from the live/dead 
assay demonstrated that after four hours, the ratio of live/dead 
bacteria was significantly lower in the solution with the high-
est dose (3 mg/mL) of IO nanoparticles compared with the 
control sample as well as the low and medium dose samples; 
the same trend was observed after 12 hours and 24 hours 
(Figure 8).
There are several factors that caused the presently studied 
IO nanoparticles to be bactericidal. The main mechanism by 
which antibacterial drugs and antibiotics work is via oxidative 
stress generated by ROS.27 ROS, including superoxide 
radicals (O2
−), hydroxyl radicals (−OH), hydrogen peroxide 
(H2O2), and singlet oxygen (1O2), can cause damage to pro-
teins and DNA in bacteria.28 Park et al also demonstrated 
an antibacterial activity from silver metals because of ROS 
generation.29 In this case, metal oxide Fe3O4 could be the 
source that created ROS leading to the inhibition of S. aureus. 
A similar process was described by Keenan et al in which 
Fe2+ reacted with oxygen to create hydrogen peroxide.30 This 
H2O2 consequently reacted with ferrous irons via the Fenton 
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Figure 4 Zeta potential of IO nanoparticles in an aqueous solution was measured by a Malvern Zetasizer-nano instrument. Average zeta potential was −19.09 mV.
Abbreviation: IO, iron oxide.
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Figure 5 X-ray diffraction results of synthesized nanoparticles confirmed the existence of magnetite (Fe3O4) and maghemite γ-Fe2O3.International Journal of Nanomedicine 2010:5 281
Antibacterial effects of iron oxide nanoparticles Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
reaction and produced hydroxyl radicals which are known to 
damage biological macromolecules.17
Other research has demonstrated that the small size of 
nanoparticles can also contribute to bactericidal effects. 
For example, Lee et al reported that the inactivation 
of Escherichia coli by zero-valent iron nanoparticles31 
could be because of the penetration of the small particles 
(sizes ranging from 10–80 nm) into E. coli membranes. 
Nano-Fe0 could then react with intracellular oxygen, leading 
to oxidative stress and eventually causing disruption of the 
cell membrane. Several other studies on ZnO and MgO 
nanoparticles also concluded that antibacterial activity 
increased with decreasing particle size.32–34
In this study, the concentration of nanoparticles was 
a major contribution to S. aureus activity inhibition. 
A similar concentration-dependent behavior was observed 
by Kim et al when they investigated the antimicrobial effects 
of Ag and ZnO nanoparticles on S. aureus and E. coli.32,35 
In a study of bactericidal effects of IO nanoparticles on 
S. epidermidis, Taylor et al also reported concentration-
dependent bacteria inhibition.36 Briefly, S. epidermidis 
density progressively decreased at time points of 12, 24, 
and 48 hours when incubated with 100 µg/mL, 1 mg/mL, 
and 2 mg/mL IO.
It is also important to note that IO nanoparticles do not 
negatively influence all cells. Specifically, osteoblast (bone-
forming cell) proliferation was enhanced in the presence 
of Fe2O3 nanoparticles (at 4.25 mg/mL, the same order of 
magnitude which inhibited bacteria in this study).9 Such 
results showed that IO nanoparticles could have a dual 
therapeutic function which can enhance bone growth and 
inhibit bacteria infection. Lastly, this present study provided 
evidence that with an appropriate external magnetic field, IO 
magnetic particles may be directed to kill bacteria as needed 
throughout the body.
M
o
m
e
n
t
 
(
e
m
u
/
g
)
Field (G)
15
−15
10
−10
5
−5
0
−12000 12000 −8000 8000 −4000 4000 0
Figure 6 Magnetization curves of IO/PVA nanoparticles as measured by VSM at 
room temperature. The results clearly showed superparamagnetic behavior of the 
nanoparticles.
Abbreviations: IO, iron oxide; PVA, polyvinyl alcohol; VSM, vibrating sample 
  magnometry.
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Figure 7 Optical density reading of bacteria in IO/PVA solution after four hours, 12 hours, and 24 hours. The results are mean ± SEM. (n = 3). All densities are significantly 
(*P  0.01) greater at 12 and 24 hours compared with the four-hour time point.
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Conclusions
Stable IO/PVA nanoparticles were successfully synthe-
sized. The particles were characterized with TEM, dynamic 
light scattering, XRD and VSM. A live/dead assay showed 
that at the highest dose of iron oxide (3 mg/mL), the growth 
of S. aureus was inhibited significantly compared with the 
control samples. Further studies should investigate the 
bactericidal effect of iron oxide nanoparticles on other 
types of bacteria for potentially widening such antibacte-
rial applications.
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